These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31368418)

  • 1. Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation.
    Wang A; Yan X; Liang R; Wang L; Chu L; Sun K; Fu F
    Pharm Dev Technol; 2019 Dec; 24(10):1229-1235. PubMed ID: 31368418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics.
    Zhai J; Ou Z; Zhong L; Wang YE; Cao LP; Guan S
    Drug Deliv; 2020 Nov; 27(1):1667-1675. PubMed ID: 33241694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
    J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
    Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
    Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP
    Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation.
    Wu J; Williams GR; Branford-White C; Li H; Li Y; Zhu LM
    Eur J Pharm Sci; 2016 Sep; 92():28-38. PubMed ID: 27343696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.
    Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.
    Qi F; Wu J; Fan Q; He F; Tian G; Yang T; Ma G; Su Z
    Colloids Surf B Biointerfaces; 2013 Dec; 112():492-8. PubMed ID: 24075786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Acting Release Microspheres Containing Novel GLP-1 Analog as an Antidiabetic System.
    Ruan S; Gu Y; Liu B; Gao H; Hu X; Hao H; Jin L; Cai T
    Mol Pharm; 2018 Jul; 15(7):2857-2869. PubMed ID: 29763559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono-PEGylates of exenatide in branched and dimeric structures can improve in vivo stability and hypoglycemic bioactivity.
    Thi Nguyen NT; Jung S; Lee SH; Bae ON; Lee EK
    J Biotechnol; 2019 Dec; 306():89-96. PubMed ID: 31580912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus.
    Oh KS; Kim JY; Yoon BD; Lee M; Kim H; Kim M; Seo JH; Yuk SH
    Eur J Pharm Biopharm; 2014 Nov; 88(3):664-9. PubMed ID: 25152212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres.
    Qi F; Wu J; Hao D; Yang T; Ren Y; Ma G; Su Z
    Pharm Res; 2014 Jun; 31(6):1566-74. PubMed ID: 24398695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice.
    Liang R; Li X; Zhang R; Shi Y; Wang A; Chen D; Sun K; Liu W; Li Y
    Pharm Res; 2014 Aug; 31(8):1958-66. PubMed ID: 24549820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology model.
    Voronova V; Zhudenkov K; Penland RC; Boulton DW; Helmlinger G; Peskov K
    Diabetes Obes Metab; 2018 Aug; 20(8):2034-2038. PubMed ID: 29663628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes.
    Zhang Y; Zhong Y; Hu M; Xiang N; Fu Y; Gong T; Zhang Z
    Drug Dev Ind Pharm; 2016; 42(7):1042-9. PubMed ID: 26558908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties.
    Li C; Cai X; Dai Y; Liu C; Bi X; Zhou J; Li Q; Sun L; Huang W; Hou Z; Qian H
    Bioorg Med Chem; 2019 Oct; 27(20):115070. PubMed ID: 31471103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets.
    Lew B; Kim IY; Choi H; Kim KK
    Drug Deliv Transl Res; 2018 Jun; 8(3):857-862. PubMed ID: 29372538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats.
    Shi S; Song S; Liu X; Zhao G; Ding F; Zhao W; Zhang S; Song Y; Ma W
    Drug Deliv; 2022 Dec; 29(1):548-560. PubMed ID: 35156499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-acting injectable microspheres of glucagon-like peptide-1].
    Yin DF; Wu C; Lu Y; Zhu Y; Zhong YQ
    Yao Xue Xue Bao; 2006 Jul; 41(7):603-7. PubMed ID: 17007350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.